Celldex Therapeutics
0 sources
Financials
0001104659-26-019652Celldex Therapeutics
Summary
Celldex Therapeutics is a business[1].
Key Facts
- Celldex Therapeutics is in the country of United States[2].
- Celldex Therapeutics is in the country of US[3].
- Celldex Therapeutics's instance of is recorded as business[4].
- Celldex Therapeutics's headquarters location is recorded as Hampton[5].
- Celldex Therapeutics's stock exchange is recorded as Nasdaq[6].
- January 1, 1983 marks the founding of Celldex Therapeutics[7].
- Celldex Therapeutics's official website is recorded as http://www.celldex.com/[8].
- Celldex Therapeutics's legal form is recorded as 8888[9].
Product Details
The following facts are restated verbatim from public-domain and CC0 open-data sources — every line is independently verifiable against the named source's catalog.
GLEIF Golden Copy — Level 1 entity data
-
Legal Entity Identifier (LEI): 529900F018DMYWH38923[10]
-
Registered legal name: Celldex Therapeutics, Inc.[11]
-
Legal jurisdiction: US-DE[12]
-
GLEIF entity category: GENERAL[13]
-
Legal form (ISO 20275 ELF): 8888[14]
-
Other legal form: Corporation[15]
-
Entity status: ACTIVE[16]
-
LEI registration status: LAPSED[17]
-
LEI first registered: 2018-11-23[18]
-
LEI last updated: 2021-07-15[19]
-
LEI next renewal: 2019-11-23[20]
-
Managing LOU: 5299000J2N45DDNE4Y28[21]
-
Registration authority: RA000602[22]
-
Authority entity ID: 2023075[23]
-
Conformity flag: NON_CONFORMING[24]
Body
Founding
January 1, 1983 marks the founding of Celldex Therapeutics[7].
Operations
Celldex Therapeutics's headquarters location is recorded as Hampton[5].
Ownership
Celldex Therapeutics's stock exchange is recorded as Nasdaq[6].